Latest

AI
AMD Closes Taalas Deal in Specialized Inference Push
AMD previously valued the cash-and-stock transaction at about $2.9 billion, including up to about $1.4 billion in contingent payments.

Technology
GlobalFoundries to Test Atlas Humanoids in Early 2027
Boston Dynamics will also expand Spot inspections across four manufacturing locations, building on deployments in Vermont and Singapore.

TradFi & Fintech
Waller Backs Traditional Rails for Tokenized Markets
The Fed governor says programmable money can coexist with conventional settlement, with netting still useful when institutions need to conserve liquidity.

Infrastructure
How to Verify an AI Compliance Alert Before Acting
Check the original evidence and the identity involved, separate fact-finding from authority to act, and preserve corrections alongside the final sign-off.

Security
What Is a Hardware Wallet, and What Does It Protect?
The device protects signing keys, not coins stored inside it. Following a payment shows why keeping keys isolated does not guarantee a safe destination or contract.

AI
Anthropic Said to Guide IPO Price to $78 or Higher
At $78, the base share sale would be worth about $64.4 billion before fees. Final pricing is expected Nov. 18, subject to regulatory clearance.

CeFi
Coinbase Adds User-Approved Trading Inside ChatGPT
The official plugin is available to US Coinbase users, subject to account eligibility, and requires confirmation for orders, edits and cancellations.

DeFi
Grvt Launches Commodity Perps With Weekday Funding
Gold, silver and WTI oil lead the alpha rollout, which uses market makers’ traditional financing costs rather than price-gap-based funding.

Security
Aster Says It Tightened Security After API Wallet Leak
A trader alleges $4.56 million in unauthorized transfers. CEO Leonard told users with suspected key exposure to delete the affected API Wallet from a trusted device.

AI
Isomorphic Labs Raises $5 Billion for AI Drug Design
Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.





